April 20, 2020 - April 21, 2020
Washington, United States
The cannabis industry is rapidly growing and will exceed 25 billion in North America alone. The wave has clearly turned in legalization of marijuana for medical use and legal recreational use on the rise. FDA is aware that patients, caregivers and the pharmaceutical industry alike want alternatives to unmet medical needs and supports sound scientific research. Now is the time for the cannabis and pharmaceutical industries to converge to map a path forward in best practices in research and development and GMP compliance. KENX is proud to present Pharmaceutical Cannabis Compliance Congress on April 20-21, 2020 in Washington D.C. Whether you are in the Life Science or Cannabis in Science, R&D or Compliance this is a must attend to event to drive this important environment and movement forward.
Who Should Attend:
Life Science and Cannabis Industries